» Articles » PMID: 32584821

Concurrent Advanced HIV Disease and Viral Load Suppression in a High-burden Setting: Findings from the 2015-6 ZIMPHIA Survey

Overview
Journal PLoS One
Date 2020 Jun 26
PMID 32584821
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: As Zimbabwe approaches epidemic control of HIV, programs now prioritize viral load over CD4 monitoring, making it difficult to identify persons living with HIV (PLHIV) suffering from advanced disease (AD). We present an analysis of cross-sectional ZIMPHIA data, highlighting PLHIV with AD and concurrent viral load suppression (VLS).

Methods: ZIMPHIA collected blood specimens for HIV testing from 22,501 consenting adults (ages 15 years and older); 3,466 PLHIV had CD4 and VL results. Household HIV testing used the national serial algorithm, and those testing positive then received point-of-care CD4 enumeration with subsequent VL testing. We used logistic regression analysis to explore factors associated with concurrent AD and VLS (<1000 copies/mL). All analyses were weighted to account for complex survey design.

Results: Of the 3,466 PLHIV in the survey with CD4 and VL results, 17% were found to have AD (CD4<200cells/mm3). Of all AD patients, 30% had VLS. Concurrent AD and VLS was associated with male sex (aOR 2.45 95%CI 1.61-3.72), older age (35-49 years [aOR 2.46 95%CI 1.03-5.91] and 50+ years [aOR 4.82 95%CI 2.02-11.46] vs 15-24 years), and ART duration (<6 months [aOR 0.46 95%CI 0.29-0.76] and 6-24 months [aOR 2.07 95%CI 1.35-3.17] vs more than 2 years). The relationship between sex and AD is driven by age with significant associations among men aged 25-34, (aOR 3.37 95%CI 1.35-8.41), 35-49 (aOR 5.13 95%CI 2.16-12.18), and 50+ (aOR 12.56 95%CI 4.82-32.72) versus men aged 15-24.

Conclusions: The percentage of PLHIV with AD and VLS illustrates the conundrum of decreased support for CD4 monitoring, as these patients may not receive appropriate clinical services for advanced HIV disease. In high-prevalence settings such as Zimbabwe, CD4 monitoring support warrants further consideration to differentiate care appropriately for the most vulnerable PLHIV. Males may need to be prioritized, given their over-representation in this sub-population.

Citing Articles

Persistent advanced HIV disease in rural KwaZulu-Natal, South Africa: Trends, characteristics, and the urgent need for targeted interventions.

Kitenge M, Fatti G, Eshun-Wilson I, Nyasulu P PLoS One. 2025; 20(2):e0317674.

PMID: 39965033 PMC: 11835316. DOI: 10.1371/journal.pone.0317674.


Advanced HIV disease in East Africa and Nigeria, in The African Cohort Study.

Oboho I, Esber A, Dear N, Paulin H, Iroezindu M, Bahemana E J Acquir Immune Defic Syndr. 2024; 96(1):51-60.

PMID: 38427929 PMC: 11008437. DOI: 10.1097/QAI.0000000000003392.


Rapid antiretroviral therapy initiation in patients with advanced HIV disease: 6-month outcomes of an observational cohort evaluation in Lesotho.

Tiam A, Paulin H, Machekano R, Oboho I, Agyemang E, Mugyenyi F PLoS One. 2023; 18(10):e0292660.

PMID: 37819941 PMC: 10566720. DOI: 10.1371/journal.pone.0292660.


Progress Towards UNAIDS's 95-95-95 Targets in Zimbabwe: Sociodemographic Constraints and Geospatial Heterogeneity.

Chowdhury M, Bershteyn A, Milali M, Citron D, Nyimbili S, Musuka G medRxiv. 2023; .

PMID: 37546877 PMC: 10402226. DOI: 10.1101/2023.07.26.23293207.


Point of Care CD4 Testing in National Household Surveys - Results and Quality Indicators from Eleven Population-Based HIV Impact Assessment (PHIA) Surveys.

Birhanu S, Winterhalter F, Stupp P, Cates M, Rottinghaus E, Yavo D Microbiol Spectr. 2023; 11(3):e0314822.

PMID: 37071009 PMC: 10269725. DOI: 10.1128/spectrum.03148-22.


References
1.
Reynolds S, Sempa J, Kiragga A, Newell K, Nakigozi G, Galiwango R . Is CD4 monitoring needed among ugandan clients achieving a virologic and immunologic response to treatment?. AIDS Patient Care STDS. 2014; 28(11):575-8. PMC: 4227437. DOI: 10.1089/apc.2014.0086. View

2.
Hallfors D, Iritani B, Zhang L, Hartman S, Luseno W, Mpofu E . 'I thought if I marry the prophet I would not die': The significance of religious affiliation on marriage, HIV testing, and reproductive health practices among young married women in Zimbabwe. SAHARA J. 2016; 13(1):178-187. PMC: 5642446. DOI: 10.1080/17290376.2016.1245627. View

3.
Nyika H, Mugurungi O, Shambira G, Gombe N, Bangure D, Mungati M . Factors associated with late presentation for HIV/AIDS care in Harare City, Zimbabwe, 2015. BMC Public Health. 2016; 16:369. PMC: 4855488. DOI: 10.1186/s12889-016-3044-7. View

4.
Takuva S, Maskew M, Brennan A, Long L, Sanne I, Fox M . Poor CD4 recovery and risk of subsequent progression to AIDS or death despite viral suppression in a South African cohort. J Int AIDS Soc. 2014; 17:18651. PMC: 3942566. DOI: 10.7448/IAS.17.1.18651. View

5.
Nanzigu S, Kiguba R, Kabanda J, Mukonzo J, Waako P, Kityo C . Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans. HIV AIDS (Auckl). 2013; 5:309-19. PMC: 3857165. DOI: 10.2147/HIV.S50614. View